Locus Cell Statistics
Total Valuation
Locus Cell has a market cap or net worth of TWD 5.91 billion. The enterprise value is 4.56 billion.
Market Cap | 5.91B |
Enterprise Value | 4.56B |
Important Dates
The next estimated earnings date is Wednesday, November 13, 2024.
Earnings Date | Nov 13, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
Locus Cell has 200.00 million shares outstanding.
Shares Outstanding | 200.00M |
Shares Change (YoY) | n/a |
Shares Change (QoQ) | n/a |
Owned by Insiders (%) | 2.52% |
Owned by Institutions (%) | 0.02% |
Float | 87.13M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 5,682.69 |
PB Ratio | 3.32 |
P/FCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | -41.72 |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | -11.51 |
Financial Position
The company has a current ratio of 16.50, with a Debt / Equity ratio of 3.99.
Current Ratio | 16.50 |
Quick Ratio | 16.17 |
Debt / Equity | 3.99 |
Debt / EBITDA | n/a |
Debt / FCF | -0.18 |
Interest Coverage | -123.13 |
Financial Efficiency
Return on equity (ROE) is -5.98% and return on invested capital (ROIC) is -5.10%.
Return on Equity (ROE) | -5.98% |
Return on Assets (ROA) | -4.99% |
Return on Capital (ROIC) | -5.10% |
Revenue Per Employee | 31,515 |
Profits Per Employee | -3.31M |
Employee Count | 33 |
Asset Turnover | 0.00 |
Inventory Turnover | 0.92 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -14.96% in the last 52 weeks.
Beta (5Y) | n/a |
52-Week Price Change | -14.96% |
50-Day Moving Average | 29.27 |
200-Day Moving Average | 29.83 |
Relative Strength Index (RSI) | 53.48 |
Average Volume (20 Days) | 183,408 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Locus Cell had revenue of TWD 1.04 million and -109.33 million in losses. Loss per share was -0.55.
Revenue | 1.04M |
Gross Profit | 387,000 |
Operating Income | -155.39M |
Pretax Income | -109.33M |
Net Income | -109.33M |
EBITDA | -149.01M |
EBIT | -155.39M |
Loss Per Share | -0.55 |
Balance Sheet
The company has 1.42 billion in cash and 71.00 million in debt, giving a net cash position of 1.35 billion or 6.74 per share.
Cash & Cash Equivalents | 1.42B |
Total Debt | 71.00M |
Net Cash | 1.35B |
Net Cash Per Share | 6.74 |
Equity (Book Value) | 1.78B |
Book Value Per Share | 8.89 |
Working Capital | 1.37B |
Cash Flow
In the last 12 months, operating cash flow was -87.82 million and capital expenditures -308.50 million, giving a free cash flow of -396.32 million.
Operating Cash Flow | -87.82M |
Capital Expenditures | -308.50M |
Free Cash Flow | -396.32M |
FCF Per Share | -1.98 |
Margins
Gross Margin | 37.21% |
Operating Margin | -14,941.73% |
Pretax Margin | -10,512.40% |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | -38,107.40% |
Dividends & Yields
Locus Cell does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | n/a |
Shareholder Yield | n/a |
Earnings Yield | -1.85% |
FCF Yield | -6.71% |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |